Pressure Biosciences Inc (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,191 | -8,074 | -29,314 | -19,411 | -13,781 |
| Depreciation Amortization | 2,447 | 1,648 | 2,620 | 3,298 | 1,882 |
| Accounts receivable | -28 | 12 | 144 | -34 | 106 |
| Accounts payable and accrued liabilities | -171 | -226 | 683 | 425 | 275 |
| Other Working Capital | 2,397 | 693 | 4,135 | 2,265 | 1,534 |
| Other Operating Activity | 7,980 | 4,088 | 18,546 | 11,402 | 8,662 |
| Operating Cash Flow | $-2,566 | $-1,860 | $-3,186 | $-2,054 | $-1,321 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -8 | -8 | -3 |
| Investing Cash Flow | $N/A | $N/A | $-8 | $-8 | $-3 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 547 | 2,151 | 2,615 | 6,380 | 1,910 |
| Debt Issued | 2,787 | 97 | 5,639 | 159 | 3,622 |
| Debt Repayment | -759 | N/A | -2,927 | -2,462 | -2,502 |
| Common Stock Issued | 0 | N/A | 231 | 231 | 231 |
| Other Financing Activity | -78 | -466 | -2,286 | -2,246 | -1,916 |
| Financing Cash Flow | $2,498 | $1,782 | $3,271 | $2,063 | $1,346 |
| Beginning Cash Position | 81 | 81 | 4 | 4 | 4 |
| End Cash Position | 14 | 3 | 81 | 5 | 25 |
| Net Cash Flow | $-67 | $-78 | $77 | $1 | $21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,566 | -1,860 | -3,186 | -2,054 | -1,321 |
| Capital Expenditure | N/A | N/A | -8 | -8 | -3 |
| Free Cash Flow | -2,566 | -1,860 | -3,194 | -2,061 | -1,324 |